Short-term induction glucocorticoids and disease-modifying anti-rheumatic drugs (DMARD) therapy for rheumatoid arthritis

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the benefits and harms of bridging GC when used in combination with DMARD therapy at time of DMARD initiation or switch in the treatment of patients with active RA. 

This is a protocol.